{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T19:35:56Z","timestamp":1787859356377,"version":"build-2784847793"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["32570773 and 32270690"],"award-info":[{"award-number":["32570773 and 32270690"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Pioneer and Leading Goose R&D Program of Zhejiang Province","award":["2026C01022"],"award-info":[{"award-number":["2026C01022"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Probiotics & Antimicro. Prot."],"DOI":"10.1007\/s12602-026-11099-3","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T01:35:48Z","timestamp":1781228148000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Modulating the Gut-Liver Axis: Anti-Inflammatory Mechanisms of Probiotics and Prebiotics in MASLD"],"prefix":"10.1007","author":[{"given":"Amin","family":"Ullah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bairong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"11099_CR1","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","volume":"81","author":"F Tacke","year":"2024","unstructured":"Tacke F, Horn P, Wai-Sun Wong V et al (2024) EASL\u2013EASD\u2013EASO Clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J Hepatol 81:492\u2013542. https:\/\/doi.org\/10.1016\/j.jhep.2024.04.031","journal-title":"J Hepatol"},{"key":"11099_CR2","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V et al (2023) A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology 78:1966\u20131986. https:\/\/doi.org\/10.1097\/HEP.0000000000000520","journal-title":"Hepatology"},{"key":"11099_CR3","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","volume":"184","author":"R Loomba","year":"2021","unstructured":"Loomba R, Friedman SL, Shulman GI (2021) Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell 184:2537\u20132564. https:\/\/doi.org\/10.1016\/j.cell.2021.04.015","journal-title":"Cell"},{"key":"11099_CR4","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","volume":"77","author":"ZM Younossi","year":"2023","unstructured":"Younossi ZM, Golabi P, Paik JM et al (2023) The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology 77:1335\u20131347. https:\/\/doi.org\/10.1097\/HEP.0000000000000004","journal-title":"Hepatology"},{"key":"11099_CR5","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1111\/liv.13270","volume":"37","author":"H Perazzo","year":"2017","unstructured":"Perazzo H, Dufour JF (2017) The therapeutic landscape of non-alcoholic steatohepatitis. Liver Int 37:634\u2013647. https:\/\/doi.org\/10.1111\/liv.13270","journal-title":"Liver Int"},{"key":"11099_CR6","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.jnutbio.2009.05.006","volume":"20","author":"A Spruss","year":"2009","unstructured":"Spruss A, Bergheim I (2009) Dietary fructose and intestinal barrier: potential risk factor in the pathogenesis of nonalcoholic fatty liver disease. J Nutr Biochem 20:657\u2013662. https:\/\/doi.org\/10.1016\/j.jnutbio.2009.05.006","journal-title":"J Nutr Biochem"},{"key":"11099_CR7","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.jhep.2008.01.035","volume":"48","author":"I Bergheim","year":"2008","unstructured":"Bergheim I, Weber S, Vos M et al (2008) Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: Role of endotoxin. J Hepatol 48:983\u2013992. https:\/\/doi.org\/10.1016\/j.jhep.2008.01.035","journal-title":"J Hepatol"},{"key":"11099_CR8","doi-asserted-by":"publisher","first-page":"15518","DOI":"10.3748\/wjg.v20.i42.15518","volume":"20","author":"G Paolella","year":"2014","unstructured":"Paolella G, Mandato C, Pierri L et al (2014) Gut-liver axis and probiotics: Their role in non-alcoholic fatty liver disease. World J Gastroenterol 20:15518\u201315531. https:\/\/doi.org\/10.3748\/wjg.v20.i42.15518","journal-title":"World J Gastroenterol"},{"key":"11099_CR9","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.3390\/nu13092989","volume":"13","author":"H-B Lee","year":"2021","unstructured":"Lee H-B, Do M-H, Jhun H et al (2021) Amelioration of Hepatic Steatosis in Mice through Bacteroides uniformis CBA7346-Mediated Regulation of High-Fat Diet-Induced Insulin Resistance and Lipogenesis. Nutrients 13:2989","journal-title":"Nutrients"},{"key":"11099_CR10","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1038\/s41591-018-0061-3","volume":"24","author":"L Hoyles","year":"2018","unstructured":"Hoyles L, Fern\u00e1ndez-Real JM, Federici M et al (2018) Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women. Nat Med 24:1070\u20131080. https:\/\/doi.org\/10.1038\/s41591-018-0061-3","journal-title":"Nat Med"},{"key":"11099_CR11","doi-asserted-by":"publisher","first-page":"G42","DOI":"10.1152\/ajpgi.00017.2023","volume":"325","author":"B Kaufmann","year":"2023","unstructured":"Kaufmann B, Seyfried N, Hartmann D, Hartmann P (2023) Probiotics, prebiotics, and synbiotics in nonalcoholic fatty liver disease and alcohol-associated liver disease. Am J Physiol - Gastrointest Liver Physiol 325:G42\u2013G61. https:\/\/doi.org\/10.1152\/ajpgi.00017.2023","journal-title":"Am J Physiol - Gastrointest Liver Physiol"},{"key":"11099_CR12","doi-asserted-by":"publisher","first-page":"7577","DOI":"10.1007\/s13197-015-1921-1","volume":"52","author":"KR Pandey","year":"2015","unstructured":"Pandey KR, Naik SR, Vakil BV (2015) Probiotics, prebiotics and synbiotics- a review. J Food Sci Technol 52:7577\u20137587. https:\/\/doi.org\/10.1007\/s13197-015-1921-1","journal-title":"J Food Sci Technol"},{"key":"11099_CR13","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s00253-021-11646-8","volume":"106","author":"MK Yadav","year":"2022","unstructured":"Yadav MK, Kumari I, Singh B et al (2022) Probiotics, prebiotics and synbiotics: safe options for next-generation therapeutics. Appl Microbiol Biotechnol 106:505\u2013521. https:\/\/doi.org\/10.1007\/s00253-021-11646-8","journal-title":"Appl Microbiol Biotechnol"},{"key":"11099_CR14","doi-asserted-by":"publisher","unstructured":"Li D, Li Y, Yang S et al (2022) Diet-gut microbiota-epigenetics in metabolic diseases: from mechanisms to therapeutics. Biomed Pharmacother 153:113290, 113290. https:\/\/doi.org\/10.1016\/j.biopha.2022.113290","DOI":"10.1016\/j.biopha.2022.113290"},{"key":"11099_CR15","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","volume":"72","author":"A Albillos","year":"2020","unstructured":"Albillos A, de Gottardi A, Rescigno M (2020) The gut-liver axis in liver disease: pathophysiological basis for therapy. J Hepatol 72:558\u2013577. https:\/\/doi.org\/10.1016\/j.jhep.2019.10.003","journal-title":"J Hepatol"},{"key":"11099_CR16","doi-asserted-by":"publisher","unstructured":"Ullah A, Pervaz S, Adu-gyamfi EA et al (2022) CXCL13 and CXCR5 are upregulated in PCOS mice ovaries but downregulated following metformin administration. Mol Cell Endocrinol 556:111730, 111730. https:\/\/doi.org\/10.1016\/j.mce.2022.111730","DOI":"10.1016\/j.mce.2022.111730"},{"key":"11099_CR17","doi-asserted-by":"publisher","unstructured":"Ullah A, Ud Din A, Ding W et al (2023) A narrative review: CXC chemokines influence immune surveillance in obesity and obesity-related diseases: type 2 diabetes and nonalcoholic fatty liver disease. Rev Endocr Metab Disord. https:\/\/doi.org\/10.1007\/s11154-023-09800-w","DOI":"10.1007\/s11154-023-09800-w"},{"key":"11099_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcell.2023.1272536","volume":"11","author":"A Ullah","year":"2023","unstructured":"Ullah A, Zhao J, Singla RK, Shen B (2023) Pathophysiological impact of CXC and CX3CL1 chemokines in preeclampsia and gestational diabetes mellitus. Front Cell Dev Biol 11:1\u201320. https:\/\/doi.org\/10.3389\/fcell.2023.1272536","journal-title":"Front Cell Dev Biol"},{"key":"11099_CR19","doi-asserted-by":"publisher","first-page":"122277","DOI":"10.1016\/j.lfs.2023.122277","volume":"336","author":"A Ullah","year":"2024","unstructured":"Ullah A, Zhao J, Li J et al (2024) Involvement of CXC chemokines (CXCL1-CXCL17) in gastric cancer: Prognosis and therapeutic molecules. Life Sci 336:122277. https:\/\/doi.org\/10.1016\/j.lfs.2023.122277","journal-title":"Life Sci"},{"key":"11099_CR20","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s11154-024-09884-y","volume":"25","author":"A Ullah","year":"2024","unstructured":"Ullah A, Singla RK, Batool Z et al (2024) Pro- and anti-inflammatory cytokines are the game-changers in childhood obesity-associated metabolic disorders (diabetes and non-alcoholic fatty liver diseases). Rev Endocr Metab Disord 25:783\u2013803. https:\/\/doi.org\/10.1007\/s11154-024-09884-y","journal-title":"Rev Endocr Metab Disord"},{"key":"11099_CR21","doi-asserted-by":"publisher","first-page":"CXCL1","DOI":"10.1186\/s11658-024-00591-9","volume":"29","author":"A Ullah","year":"2024","unstructured":"Ullah A, Jiao W, Shen B (2024) The role of proinflammatory cytokines and CXC chemokines (CXCL1\u2013CXCL16) in the progression of prostate cancer: insights on their therapeutic management. Cell Mol Biol Lett 29:CXCL1. https:\/\/doi.org\/10.1186\/s11658-024-00591-9","journal-title":"Cell Mol Biol Lett"},{"key":"11099_CR22","doi-asserted-by":"publisher","unstructured":"Ullah A, Chen Y, Singla RK et al (2024) Pro-inflammatory cytokines and CXC chemokines as game-changer in age-associated prostate cancer and ovarian cancer: insights from preclinical and clinical studies\u2019 outcomes. Pharmacol Res 204:107213, 107213. https:\/\/doi.org\/10.1016\/j.phrs.2024.107213","DOI":"10.1016\/j.phrs.2024.107213"},{"issue":"Suppl 2","key":"11099_CR23","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13223-018-0278-1","volume":"14","author":"JS Marshall","year":"2018","unstructured":"Marshall JS, Warrington R, Watson W, Kim HL (2018) An introduction to immunology and immunopathology. Allergy Asthma Clin Immunol 14:49. https:\/\/doi.org\/10.1186\/s13223-018-0278-1","journal-title":"Allergy Asthma Clin Immunol"},{"key":"11099_CR24","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s13679-025-00657-5","volume":"14","author":"ID Vachliotis","year":"2025","unstructured":"Vachliotis ID, Polyzos SA (2025) The Intriguing Roles of Cytokines in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Narrative Review. Curr Obes Rep 14:65. https:\/\/doi.org\/10.1007\/s13679-025-00657-5","journal-title":"Curr Obes Rep"},{"key":"11099_CR25","doi-asserted-by":"publisher","first-page":"102505","DOI":"10.1016\/j.arr.2024.102505","volume":"101","author":"A Ullah","year":"2024","unstructured":"Ullah A, Chen Y, Singla RK et al (2024) Exploring Cytokines Dynamics: Uncovering Therapeutic Concepts for Metabolic Disorders in Postmenopausal Women- Diabetes, Metabolic Bone Diseases, and Non-Alcohol Fatty Liver Disease. Ageing Res Rev 101:102505. https:\/\/doi.org\/10.1016\/j.arr.2024.102505","journal-title":"Ageing Res Rev"},{"key":"11099_CR26","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.3748\/wjg.v20.i7.1807","volume":"20","author":"SM Alwahsh","year":"2014","unstructured":"Alwahsh SM, Xu M, Seyhan HA et al (2014) Diet high in fructose leads to an overexpression of lipocalin-2 in rat fatty liver. World J Gastroenterol 20:1807\u20131821. https:\/\/doi.org\/10.3748\/wjg.v20.i7.1807","journal-title":"World J Gastroenterol"},{"key":"11099_CR27","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1002\/ame2.12337","volume":"7","author":"D Liu","year":"2024","unstructured":"Liu D, Chen P (2024) Binary Bacillus subtilis protects the intestinal mucosa barrier and alleviates nonalcoholic steatohepatitis. Anim Model Exp Med 7:362\u2013366. https:\/\/doi.org\/10.1002\/ame2.12337","journal-title":"Anim Model Exp Med"},{"key":"11099_CR28","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1186\/s12876-024-03356-y","volume":"24","author":"Y Pan","year":"2024","unstructured":"Pan Y, Yang Y, Wu J et al (2024) Efficacy of probiotics, prebiotics, and synbiotics on liver enzymes, lipid profiles, and inflammation in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials. BMC Gastroenterol 24:283. https:\/\/doi.org\/10.1186\/s12876-024-03356-y","journal-title":"BMC Gastroenterol"},{"key":"11099_CR29","doi-asserted-by":"publisher","first-page":"5944","DOI":"10.3390\/ijms26135944","volume":"26","author":"KS Chang","year":"2025","unstructured":"Chang KS, Kuo WH, Chang MH et al (2025) Gut Microbiota and Liver Health: Meta-Analysis of Bifidobacterium-Containing Probiotics in NAFLD Management. Int J Mol Sci 26:5944. https:\/\/doi.org\/10.3390\/ijms26135944","journal-title":"Int J Mol Sci"},{"key":"11099_CR30","doi-asserted-by":"publisher","first-page":"3340","DOI":"10.1007\/s10620-015-3770-1","volume":"60","author":"W Sohn","year":"2015","unstructured":"Sohn W, Jun DW, Lee KN et al (2015) Lactobacillus paracasei Induces M2-Dominant Kupffer Cell Polarization in a Mouse Model of Nonalcoholic Steatohepatitis. Dig Dis Sci 60:3340\u20133350. https:\/\/doi.org\/10.1007\/s10620-015-3770-1","journal-title":"Dig Dis Sci"},{"key":"11099_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00418-025-02402-4","volume":"163","author":"SM Alwahsh","year":"2025","unstructured":"Alwahsh SM, Xu M, Itmezeh A et al (2025) Excessive intake of fructose and alcohol aggravates high-fat diet-induced steatohepatitis and changes hepatic iron homeostasis. Histochem Cell Biol 163:1\u20133. https:\/\/doi.org\/10.1007\/s00418-025-02402-4","journal-title":"Histochem Cell Biol"},{"key":"11099_CR32","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1007\/s10787-018-0479-8","volume":"26","author":"Y Liang","year":"2018","unstructured":"Liang Y, Lin C, Zhang Y et al (2018) Probiotic mixture of Lactobacillus and Bifidobacterium alleviates systemic adiposity and inflammation in non-alcoholic fatty liver disease rats through Gpr109a and the commensal metabolite butyrate. Inflammopharmacology 26:1051\u20131055. https:\/\/doi.org\/10.1007\/s10787-018-0479-8","journal-title":"Inflammopharmacology"},{"key":"11099_CR33","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s12602-017-9378-3","volume":"11","author":"Y Liang","year":"2019","unstructured":"Liang Y, Liang S, Zhang Y et al (2019) Oral administration of compound probiotics ameliorates HFD-induced gut microbe dysbiosis and chronic metabolic inflammation via the G protein-coupled receptor 43 in non-alcoholic fatty liver disease rats. Probiotics Antimicrob Proteins 11:175\u2013185. https:\/\/doi.org\/10.1007\/s12602-017-9378-3","journal-title":"Probiotics Antimicrob Proteins"},{"key":"11099_CR34","doi-asserted-by":"publisher","first-page":"1121203","DOI":"10.3389\/fnut.2023.1121203","volume":"10","author":"M Yang","year":"2023","unstructured":"Yang M, Wang H, Bukhari I et al (2023) Effects of cholesterol-lowering probiotics on non-alcoholic fatty liver disease in FXR gene knockout mice. Front Nutr 10:1121203. https:\/\/doi.org\/10.3389\/fnut.2023.1121203","journal-title":"Front Nutr"},{"key":"11099_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0080169","volume":"9","author":"Y Ritze","year":"2014","unstructured":"Ritze Y, B\u00e1rdos G, Claus A et al (2014) Lactobacillus rhamnosus GG protects against non-alcoholic fatty liver disease in mice. PLoS One 9:e80169. https:\/\/doi.org\/10.1371\/journal.pone.0080169","journal-title":"PLoS One"},{"key":"11099_CR36","doi-asserted-by":"publisher","first-page":"153","DOI":"10.5604\/01.3001.0010.7547","volume":"17","author":"N Kobyliak","year":"2018","unstructured":"Kobyliak N, Abenavoli L, Falalyeyeva T, Beregova T (2018) Efficacy of probiotics and smectite in rats with non-alcoholic fatty liver disease. Ann Hepatol 17:153\u2013161. https:\/\/doi.org\/10.5604\/01.3001.0010.7547","journal-title":"Ann Hepatol"},{"key":"11099_CR37","doi-asserted-by":"publisher","unstructured":"Yan Y, Liu C, Zhao S, Zhao G et al (2020) Probiotic Bifidobacterium lactis V9 attenuates hepatic steatosis and inflammation in rats with non-alcoholic fatty liver disease. AMB Express 10:101. https:\/\/doi.org\/10.1186\/s13568-020-01038-y","DOI":"10.1186\/s13568-020-01038-y"},{"key":"11099_CR38","doi-asserted-by":"publisher","first-page":"e104220","DOI":"10.1371\/journal.pone.0104220","volume":"9","author":"SM Alwahsh","year":"2014","unstructured":"Alwahsh SM, Xu M, Schultze FC et al (2014) Combination of alcohol and fructose exacerbates metabolic imbalance in terms of hepatic damage, dyslipidemia, and insulin resistance in rats. PLoS ONE 9:e104220. https:\/\/doi.org\/10.1371\/journal.pone.0104220","journal-title":"PLoS ONE"},{"key":"11099_CR39","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3390\/ijms18020285","volume":"18","author":"SM Alwahsh","year":"2017","unstructured":"Alwahsh SM, Dwyer BJ, Forbes S et al (2017) Insulin production and resistance in different models of diet-induced obesity and metabolic syndrome. Int J Mol Sci 18:285. https:\/\/doi.org\/10.3390\/ijms18020285","journal-title":"Int J Mol Sci"},{"key":"11099_CR40","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/j.jhep.2023.07.005","volume":"79","author":"Q Song","year":"2023","unstructured":"Song Q, Zhang X, Liu W et al (2023) Bifidobacterium pseudolongum-generated acetate suppresses non-alcoholic fatty liver disease-associated hepatocellular carcinoma. J Hepatol 79:1352\u20131365. https:\/\/doi.org\/10.1016\/j.jhep.2023.07.005","journal-title":"J Hepatol"},{"key":"11099_CR41","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S1875-5364(20)30018-2","volume":"18","author":"HW YI","year":"2020","unstructured":"YI HW, ZHU XX, HUANG XL et al (2020) Selenium-enriched Bifidobacterium longum protected alcohol and high fat diet induced hepatic injury in mice. Chin J Nat Med 18:169\u2013177. https:\/\/doi.org\/10.1016\/S1875-5364(20)30018-2","journal-title":"Chin J Nat Med"},{"key":"11099_CR42","doi-asserted-by":"publisher","first-page":"111781","DOI":"10.1016\/j.biopha.2021.111781","volume":"140","author":"SH Gadallah","year":"2021","unstructured":"Gadallah SH, Eissa S, Ghanem HM et al (2021) Probiotic-prebiotic-synbiotic modulation of (YAP1, LATS1 and NF2 mRNAs\/miR-1205\/lncRNA SRD5A3-AS1) panel in NASH animal model. Biomed Pharmacother 140:111781. https:\/\/doi.org\/10.1016\/j.biopha.2021.111781","journal-title":"Biomed Pharmacother"},{"key":"11099_CR43","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1186\/s12967-022-03543-z","volume":"20","author":"NM Hany","year":"2022","unstructured":"Hany NM, Eissa S, Basyouni M et al (2022) Modulation of hepatic stellate cells by Mutaflor\u00ae probiotic in non-alcoholic fatty liver disease management. J Transl Med 20:342. https:\/\/doi.org\/10.1186\/s12967-022-03543-z","journal-title":"J Transl Med"},{"key":"11099_CR44","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12906-016-1540-z","volume":"17","author":"HM Al-muzafar","year":"2017","unstructured":"Al-muzafar HM, Amin KA (2017) Probiotic mixture improves fatty liver disease by virtue of its action on lipid profiles, leptin, and inflammatory biomarkers. BMC Complement Altern Med 17:43. https:\/\/doi.org\/10.1186\/s12906-016-1540-z","journal-title":"BMC Complement Altern Med"},{"key":"11099_CR45","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41598-022-27353-x","volume":"13","author":"N Salah","year":"2023","unstructured":"Salah N, Eissa S, Mansour A et al (2023) Evaluation of the role of kefir in management of non-alcoholic steatohepatitis rat model via modulation of NASH linked mRNA-miRNA panel. Sci Rep 13:236. https:\/\/doi.org\/10.1038\/s41598-022-27353-x","journal-title":"Sci Rep"},{"key":"11099_CR46","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13568-023-01561-8","volume":"13","author":"AM El-Baz","year":"2023","unstructured":"El-Baz AM, El-Ganiny AM, Hellal D et al (2023) Valuable effects of lactobacillus and citicoline on steatohepatitis: role of Nrf2\/HO-1 and gut microbiota. AMB Express 13:57. https:\/\/doi.org\/10.1186\/s13568-023-01561-8","journal-title":"AMB Express"},{"key":"11099_CR47","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13568-024-01731-2","volume":"14","author":"AM El-Baz","year":"2024","unstructured":"El-Baz AM, Shata A, Nouh NA et al (2024) Vinpocetine and Lactobacillus improve fatty liver in rats: role of adiponectin and gut microbiome. AMB Express 14:89. https:\/\/doi.org\/10.1186\/s13568-024-01731-2","journal-title":"AMB Express"},{"key":"11099_CR48","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jnutbio.2017.02.014","volume":"44","author":"DH Kim","year":"2017","unstructured":"Kim DH, Kim H, Jeong D et al (2017) Kefir alleviates obesity and hepatic steatosis in high-fat diet-fed mice by modulation of gut microbiota and mycobiota: targeted and untargeted community analysis with correlation of biomarkers. J Nutr Biochem 44:35\u201343. https:\/\/doi.org\/10.1016\/j.jnutbio.2017.02.014","journal-title":"J Nutr Biochem"},{"key":"11099_CR49","doi-asserted-by":"publisher","unstructured":"Sharma D, Patel D, Mandal P (2025) In vitro, in vivo, and in silico investigation of synbiotic-mediated activation of PPAR-\u03b1 curtails nonalcoholic steatohepatitis (NASH) in Wistar rats by inhibiting PNPLA3\/SREBP1-c lead inflammatory injury of hepatic cells. Mediators Inflamm 2025:9948679, 9948679. https:\/\/doi.org\/10.1155\/mi\/9948679","DOI":"10.1155\/mi\/9948679"},{"key":"11099_CR50","doi-asserted-by":"publisher","unstructured":"Mahmoudi SK, Abdolahi S, Saniee P et al (2025) Limosilactobacillus fermentum role in combination with human mesenchymal stem cell-derived secretome: A novel approach to alleviate inflammation in NASH pathogenesis. Int Immunopharmacol 156. https:\/\/doi.org\/10.1016\/j.intimp.2025.114686. 114686 Contents","DOI":"10.1016\/j.intimp.2025.114686"},{"key":"11099_CR51","doi-asserted-by":"publisher","first-page":"6298","DOI":"10.1039\/c8fo01227j","volume":"9","author":"J Zhu","year":"2018","unstructured":"Zhu J, Zhou M, Zhao X et al (2018) Blueberry, combined with probiotics, alleviates non-alcoholic fatty liver disease: via IL-22-mediated JAK1\/STAT3\/BAX signaling. Food Funct 9:6298\u20136306. https:\/\/doi.org\/10.1039\/c8fo01227j","journal-title":"Food Funct"},{"key":"11099_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/msphere.00183-20","volume":"5","author":"J-H Oh","year":"2020","unstructured":"Oh J-H, Schueler KL, Stapleton DS et al (2020) Secretion of Recombinant Interleukin-22 by Engineered Lactobacillus reuteri Reduces Fatty Liver Disease in a Mouse Model of Diet-Induced Obesity. mSphere 5:1\u20139. https:\/\/doi.org\/10.1128\/msphere.00183-20","journal-title":"mSphere"},{"key":"11099_CR53","doi-asserted-by":"publisher","first-page":"732","DOI":"10.36740\/WLek202404118","volume":"77","author":"OK Didyk","year":"2024","unstructured":"Didyk OK, Chernyavskyi VV, Shypulin VP, Tishchenko VV (2024) Effectiveness of rifaximin and probiotics for the correction of intestinal permeability in patients with metabolic-associated fatty liver disease in combination with type 2 diabetes mellitus. Wiad Lek 77:732\u2013738. https:\/\/doi.org\/10.36740\/WLek202404118","journal-title":"Wiad Lek"},{"key":"11099_CR54","doi-asserted-by":"publisher","first-page":"4939","DOI":"10.1039\/d4fo05280c","volume":"16","author":"Z Guo","year":"2025","unstructured":"Guo Z, Yang S, Qi L et al (2025) Lactobacillus acidophilus KLDS1.0901 ameliorates non-alcoholic fatty liver disease by modulating the tryptophan metabolite indole-3-aldehyde and acting on its receptor AhR. Food Funct 16:4939\u20134957. https:\/\/doi.org\/10.1039\/d4fo05280c","journal-title":"Food Funct"},{"key":"11099_CR55","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1002\/fsn3.1118","volume":"7","author":"W Wang","year":"2019","unstructured":"Wang W, Li Q, Chai W et al (2019) Lactobacillus paracasei Jlus66 extenuate oxidative stress and inflammation via regulation of intestinal flora in rats with non alcoholic fatty liver disease. Food Sci Nutr 7:2636\u20132646. https:\/\/doi.org\/10.1002\/fsn3.1118","journal-title":"Food Sci Nutr"},{"key":"11099_CR56","doi-asserted-by":"publisher","first-page":"2221485","DOI":"10.1080\/19490976.2023.2221485","volume":"15","author":"Y Han","year":"2023","unstructured":"Han Y, Ling Q, Wu L et al (2023) Akkermansia muciniphila inhibits nonalcoholic steatohepatitis by orchestrating TLR2-activated \u03b3\u03b4T17 cell and macrophage polarization. Gut Microbes 15:2221485. https:\/\/doi.org\/10.1080\/19490976.2023.2221485","journal-title":"Gut Microbes"},{"key":"11099_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/mbio.03688-21","volume":"13","author":"S He","year":"2022","unstructured":"He S, Cui S, Song W et al (2022) Interleukin-17 Weakens the NAFLD\/NASH Process by Facilitating Intestinal Barrier Restoration Depending on the Gut Microbiota. MBio 13:1\u201315. https:\/\/doi.org\/10.1128\/mbio.03688-21","journal-title":"MBio"},{"key":"11099_CR58","doi-asserted-by":"publisher","first-page":"3248","DOI":"10.2217\/hep-2017-0012","volume":"4","author":"I Fabregat","year":"2017","unstructured":"Fabregat I, Giannelli G (2017) The TGF-\u03b2 pathway: a pharmacological target in hepatocellular carcinoma? Hepat Oncol 4:3248. https:\/\/doi.org\/10.2217\/hep-2017-0012","journal-title":"Hepat Oncol"},{"key":"11099_CR59","doi-asserted-by":"publisher","unstructured":"Li B, Chi X, Huang Y et al (2024) Bifidobacterium longum-derived extracellular vesicles prevent hepatocellular carcinoma by modulating the TGF-\u03b21\/Smad signaling in mice. Front Biosci-Landmark 29:241, 241. https:\/\/doi.org\/10.31083\/j.fbl2907241","DOI":"10.31083\/j.fbl2907241"},{"key":"11099_CR60","doi-asserted-by":"publisher","first-page":"991","DOI":"10.17179\/excli2022-4791","volume":"21","author":"HM Hosseini","year":"2022","unstructured":"Hosseini HM, Shirvani H, Aghaei F et al (2022) Ameliorative Effects of High Intensity Interval Training and Lactobacillus Rhamnosus Gg Protect Against Tetracycline-Induced Fatty Liver in Rats: a Gene Expression Profiling Comparative Study. EXCLI J 21:991\u20131006. https:\/\/doi.org\/10.17179\/excli2022-4791","journal-title":"EXCLI J"},{"key":"11099_CR61","doi-asserted-by":"publisher","first-page":"66","DOI":"10.22034\/12.1.66","volume":"12","author":"S Shahmohammadi","year":"2025","unstructured":"Shahmohammadi S, Ghazalian F, Shirvani H, Abednatanzi H (2025) The effect of high intensity interval training and probiotic consumption on TGF-\u03b21 gene expression in heart tissue of male rats with steatosis. Mil Caring Sci 12:66\u201376. https:\/\/doi.org\/10.22034\/12.1.66","journal-title":"Mil Caring Sci"},{"key":"11099_CR62","doi-asserted-by":"publisher","unstructured":"Wang SL, Liang S, Li SY, Wang Z-Y-R et al (2025) Lactobacillus rhamnosus GG attenuates MASLD\/MASH progression by modulating gut microbiota and metabolic pathways. Front Microbiol 16:1586678, 1586678. https:\/\/doi.org\/10.3389\/fmicb.2025.1586678","DOI":"10.3389\/fmicb.2025.1586678"},{"key":"11099_CR63","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s12275-023-00014-y","volume":"61","author":"SM Won","year":"2023","unstructured":"Won SM, Lee NY, Oh KK et al (2023) Gut Lactobacillus and probiotics Lactobacillus lactis\/rhamnosis ameliorate liver fibrosis in prevention and treatment. J Microbiol 61:245\u2013257. https:\/\/doi.org\/10.1007\/s12275-023-00014-y","journal-title":"J Microbiol"},{"key":"11099_CR64","doi-asserted-by":"publisher","first-page":"25881","DOI":"10.3390\/ijms161025881","volume":"16","author":"WJ Ting","year":"2015","unstructured":"Ting WJ, Kuo WW, Hsieh DJY, Hsieh D et al (2015) Heat killed Lactobacillus reuteri GMNL-263 reduces fibrosis effects on the liver and heart in high fat diet-hamsters via TGF-\u03b2 suppression. Int J Mol Sci 16:25881\u201325896. https:\/\/doi.org\/10.3390\/ijms161025881","journal-title":"Int J Mol Sci"},{"key":"11099_CR65","doi-asserted-by":"publisher","first-page":"160","DOI":"10.12938\/BMFH.2024-074","volume":"44","author":"P Chonpathompikunlert","year":"2025","unstructured":"Chonpathompikunlert P, Yingthongchai P, Tateing S et al (2025) Administration of a probiotic supplement attenuates nonalcoholic fatty liver disease by reducing hepatic lipid accumulation, oxidative stress, and inflammation. Biosci Microbiota Food Health 44:160\u2013170. https:\/\/doi.org\/10.12938\/BMFH.2024-074","journal-title":"Biosci Microbiota Food Health"},{"key":"11099_CR66","doi-asserted-by":"publisher","unstructured":"Huang W, Wang G, Xia Y et al (2020) Bile salt hydrolase-overexpressing lactobacillus strains can improve hepatic lipid accumulation in vitro in an NAFLD cell model. Food Nutr Res 64:3751, 3751. https:\/\/doi.org\/10.29219\/FNR.V64.3751","DOI":"10.29219\/FNR.V64.3751"},{"key":"11099_CR67","doi-asserted-by":"publisher","first-page":"9870","DOI":"10.3390\/ijms25189870","volume":"25","author":"HJ Kim","year":"2024","unstructured":"Kim HJ, Jeon HJ, Kim DG et al (2024) Lacticaseibacillus paracsei HY7207 Alleviates Hepatic Steatosis, Inflammation, and Liver Fibrosis in Mice with Non-Alcoholic Fatty Liver Disease. Int J Mol Sci 25:9870. https:\/\/doi.org\/10.3390\/ijms25189870","journal-title":"Int J Mol Sci"},{"key":"11099_CR68","doi-asserted-by":"publisher","unstructured":"Zhu L, Huang J, Luo Z et al (2025) Lactobacillus salivarius extracellular vesicles enhance gut and liver function in MAFLD. Front Immunol 16:1660131, 1660131. https:\/\/doi.org\/10.3389\/fimmu.2025.1660131","DOI":"10.3389\/fimmu.2025.1660131"},{"key":"11099_CR69","doi-asserted-by":"publisher","first-page":"2539448","DOI":"10.1080\/19490976.2025.2539448","volume":"17","author":"J Choi","year":"2025","unstructured":"Choi J, Choi YR, Jeong MK et al (2025) Phocaeicola dorei ameliorates progression of steatotic liver disease by regulating bile acid, lipid, inflammation and proliferation. Gut Microbes 17:2539448. https:\/\/doi.org\/10.1080\/19490976.2025.2539448","journal-title":"Gut Microbes"},{"key":"11099_CR70","doi-asserted-by":"publisher","first-page":"3817","DOI":"10.1039\/d4md00477a","volume":"15","author":"M Saad","year":"2024","unstructured":"Saad M, Ibrahim W, Hasanin AH et al (2024) Evaluating the therapeutic potential of genetically engineered probiotic Zbiotics (ZB183) for non-alcoholic steatohepatitis (NASH) management via modulation of the cGAS-STING pathway. RSC Med Chem 15:3817\u20133836. https:\/\/doi.org\/10.1039\/d4md00477a","journal-title":"RSC Med Chem"},{"key":"11099_CR71","doi-asserted-by":"publisher","unstructured":"Lee JY, An M, Heo H, Lee J et al (2023) Limosilactobacillus fermentum MG4294 and Lactiplantibacillus plantarum MG5289 ameliorates nonalcoholic fatty liver disease in high-fat diet-induced mice. Nutrients. https:\/\/doi.org\/10.3390\/nu15082005","DOI":"10.3390\/nu15082005"},{"key":"11099_CR72","doi-asserted-by":"publisher","unstructured":"Zhang S, Zhao R, Wang R et al (2025) Weissella viridescens attenuates hepatic injury, oxidative stress, and inflammation in a rat model of high-fat diet-induced MASLD. Nutrients 17:1585, 1585. https:\/\/doi.org\/10.3390\/nu17091585","DOI":"10.3390\/nu17091585"},{"key":"11099_CR73","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202501250RR","volume":"39","author":"Y Tian","year":"2025","unstructured":"Tian Y, Xu Q, Wu Z et al (2025) Ameliorating effect of Bifidobacterium breve CM02-09T on high-fat diet-induced nonalcoholic fatty liver disease in mice. FASEB J 39:e70957. https:\/\/doi.org\/10.1096\/fj.202501250RR","journal-title":"FASEB J"},{"key":"11099_CR74","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3389\/fimmu.2019.00143","volume":"10","author":"J Alameddine","year":"2019","unstructured":"Alameddine J, Godefroy E, Papargyris L et al (2019) Faecalibacterium prausnitzii Skews Human DC to Prime IL10-Producing T Cells through TLR2\/6\/JNK Signaling and IL-10, IL-27, CD39, and IDO-1 Induction. Front Immunol 10:143. https:\/\/doi.org\/10.3389\/fimmu.2019.00143","journal-title":"Front Immunol"},{"key":"11099_CR75","doi-asserted-by":"publisher","first-page":"3460","DOI":"10.3390\/nu12113460","volume":"12","author":"E Stachowska","year":"2020","unstructured":"Stachowska E, Portincasa P, Jamio\u0142-Milc D et al (2020) The relationship between prebiotic supplementation and anthropometric and biochemical parameters in patients with nafld\u2014a systematic review and meta-analysis of randomized controlled trials. Nutrients 12:3460. https:\/\/doi.org\/10.3390\/nu12113460","journal-title":"Nutrients"},{"key":"11099_CR76","doi-asserted-by":"publisher","unstructured":"Moreira GV, Araujo LCC, Murata GM et al (2022) Kombucha tea improves glucose tolerance and reduces hepatic steatosis in obese mice. Biomed Pharmacother 155:113660, 113660. https:\/\/doi.org\/10.1016\/j.biopha.2022.113660","DOI":"10.1016\/j.biopha.2022.113660"},{"key":"11099_CR77","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jnutbio.2013.09.006","volume":"25","author":"RS Giuseppina Mattace Rasoa","year":"2014","unstructured":"Giuseppina Mattace Rasoa RS, Iaconoa A, Santoroa A et al (2014) Effects of a Lactobacillus paracasei B21060 based synbiotic on steatosis, insulin signaling and toll-like receptor expression in rats fed a high-fat diet. J Nutr Biochem 25:81\u201390. https:\/\/doi.org\/10.1016\/j.jnutbio.2013.09.006","journal-title":"J Nutr Biochem"},{"key":"11099_CR78","doi-asserted-by":"publisher","first-page":"115123","DOI":"10.1016\/j.foodres.2024.115123","volume":"196","author":"X Song","year":"2024","unstructured":"Song X, Sun J, Yue Y et al (2024) Microbiota-derived succinic acid mediates attenuating effect of dietary tomato juice supplementation on steatohepatitis through enhancing intestinal barrier. Food Res Int 196:115123. https:\/\/doi.org\/10.1016\/j.foodres.2024.115123","journal-title":"Food Res Int"},{"key":"11099_CR79","doi-asserted-by":"publisher","first-page":"e202401538","DOI":"10.1002\/cbdv.202401538","volume":"22","author":"Z Li","year":"2025","unstructured":"Li Z, Wang X, Li X et al (2025) Polysaccharides from Lanzhou Lily Attenuate Nonalcoholic Fatty Liver Disease Modifying the Gut Microbiota and Metabolite Profile. Chem Biodivers 22:e202401538. https:\/\/doi.org\/10.1002\/cbdv.202401538","journal-title":"Chem Biodivers"},{"key":"11099_CR80","doi-asserted-by":"publisher","first-page":"885039","DOI":"10.3389\/fendo.2022.885039","volume":"13","author":"SR Yue","year":"2022","unstructured":"Yue SR, Tan YY, Zhang L et al (2022) Gynostemma pentaphyllum polysaccharides ameliorate non-alcoholic steatohepatitis in mice associated with gut microbiota and the TLR2\/NLRP3 pathway. Front Endocrinol (Lausanne) 13:885039. https:\/\/doi.org\/10.3389\/fendo.2022.885039","journal-title":"Front Endocrinol (Lausanne)"},{"key":"11099_CR81","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/ijo.2015.197","volume":"40","author":"DP Singh","year":"2016","unstructured":"Singh DP, Khare P, Zhu J et al (2016) A novel cobiotic-based preventive approach against high-fat diet-induced adiposity, nonalcoholic fatty liver and gut derangement in mice. Int J Obes 40:487\u2013496. https:\/\/doi.org\/10.1038\/ijo.2015.197","journal-title":"Int J Obes"},{"key":"11099_CR82","doi-asserted-by":"publisher","unstructured":"Kei N, Cheung KK, Ma KL, Cheung PCK et al (2024) Effects of oat \u03b2-glucan and inulin on alleviation of nonalcoholic steatohepatitis aggravated by circadian disruption in C57BL\/6J mice. J Agric Food Chem 72:3520\u20133535. https:\/\/doi.org\/10.1021\/acs.jafc.3c08028","DOI":"10.1021\/acs.jafc.3c08028"},{"key":"11099_CR83","doi-asserted-by":"publisher","first-page":"4504","DOI":"10.1039\/d1fo00249j","volume":"12","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Chen X, Cui B (2021) Modulation of the fecal microbiome and metabolome by resistant dextrin ameliorates hepatic steatosis and mitochondrial abnormalities in mice. Food Funct 12:4504\u20134518. https:\/\/doi.org\/10.1039\/d1fo00249j","journal-title":"Food Funct"},{"key":"11099_CR84","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1016\/j.tjnut.2023.05.019","volume":"153","author":"GS Escouto","year":"2023","unstructured":"Escouto GS, Port GZ, Tovo CV et al (2023) Probiotic Supplementation, Hepatic Fibrosis, and the Microbiota Profile in Patients with Nonalcoholic Steatohepatitis: A Randomized Controlled Trial. J Nutr 153:1984\u20131993. https:\/\/doi.org\/10.1016\/j.tjnut.2023.05.019","journal-title":"J Nutr"},{"key":"11099_CR85","doi-asserted-by":"publisher","first-page":"377","DOI":"10.5152\/tjg.2017.17084","volume":"28","author":"M \u00c7akir","year":"2017","unstructured":"\u00c7akir M, I\u015fbilen AA, Ey\u00fcpo\u01e7lu I et al (2017) Effects of long-term synbiotic supplementation in addition to lifestyle changes in children with obesity-related non-alcoholic fatty liver disease. Turkish J Gastroenterol 28:377\u2013383. https:\/\/doi.org\/10.5152\/tjg.2017.17084","journal-title":"Turkish J Gastroenterol"},{"key":"11099_CR86","doi-asserted-by":"publisher","first-page":"41","DOI":"10.15403\/jgld.2014.1121.271.kby","volume":"27","author":"N Kobyliak","year":"2018","unstructured":"Kobyliak N, Abenavoli L, Mykhalchyshyn G et al (2018) A multi-strain probiotic reduces the fatty liver index, cytokines and aminotransferase levels in NAFLD patients: Evidence from a randomized clinical trial. J Gastrointest Liver Dis 27:41\u201349. https:\/\/doi.org\/10.15403\/jgld.2014.1121.271.kby","journal-title":"J Gastrointest Liver Dis"},{"key":"11099_CR87","doi-asserted-by":"publisher","first-page":"640","DOI":"10.3390\/biomedicines11020640","volume":"11","author":"N Ayob","year":"2023","unstructured":"Ayob N, Muhammad Nawawi KN, Mohamad Nor MH et al (2023) The Effects of Probiotics on Small Intestinal Microbiota Composition, Inflammatory Cytokines and Intestinal Permeability in Patients with Non-Alcoholic Fatty Liver Disease. Biomedicines 11:640. https:\/\/doi.org\/10.3390\/biomedicines11020640","journal-title":"Biomedicines"},{"key":"11099_CR88","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1080\/07315724.2015.1031355","volume":"35","author":"A Sepideh","year":"2016","unstructured":"Sepideh A, Karim P, Hossein A et al (2016) Effects of Multistrain Probiotic Supplementation on Glycemic and Inflammatory Indices in Patients with Nonalcoholic Fatty Liver Disease: A Double-Blind Randomized Clinical Trial. J Am Coll Nutr 35:500\u2013505. https:\/\/doi.org\/10.1080\/07315724.2015.1031355","journal-title":"J Am Coll Nutr"},{"key":"11099_CR89","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.6133\/apjcn.042018.05","volume":"27","author":"L Javadi","year":"2018","unstructured":"Javadi L, Khoshbaten M, Ms AS et al (2018) Pro- and prebiotic effects on oxidative stress and inflammatory markers in non-alcoholic fatty liver disease. Asia Pac J Clin Nutr 27:1031\u20131039. https:\/\/doi.org\/10.6133\/apjcn.042018.05","journal-title":"Asia Pac J Clin Nutr"},{"key":"11099_CR90","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1097\/01.mcg.0000165671.25272.0f","volume":"25","author":"CLA Federico","year":"2005","unstructured":"Federico CLA, Terracciano CT, Valeriano F, Mauro D\u2019Auria CDS, Blanco CDV (2005) Beneficial Effects of a Probiotic VSL#3 on Parameters of Liver Dysfunction in Chronic Liver Diseases. J Clin Gastroenterol 25:540\u2013543. https:\/\/doi.org\/10.1097\/01.mcg.0000165671.25272.0f","journal-title":"J Clin Gastroenterol"},{"key":"11099_CR91","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12876-015-0400-5","volume":"15","author":"JE Lambert","year":"2015","unstructured":"Lambert JE, Parnell JA, Eksteen B et al (2015) Gut microbiota manipulation with prebiotics in patients with non-alcoholic fatty liver disease: A randomized controlled trial protocol. BMC Gastroenterol 15:169. https:\/\/doi.org\/10.1186\/s12876-015-0400-5","journal-title":"BMC Gastroenterol"},{"key":"11099_CR92","doi-asserted-by":"publisher","first-page":"418","DOI":"10.23736\/S0026-4806.18.05845-7","volume":"109","author":"N Kobyliak","year":"2018","unstructured":"Kobyliak N, Abenavoli L, Falalyeyeva T et al (2018) Beneficial effects of probiotic combination with omega fatty acids in NAFLD: A randomized clinical study. Minerva Med 109:418\u2013428. https:\/\/doi.org\/10.23736\/S0026-4806.18.05845-7","journal-title":"Minerva Med"},{"key":"11099_CR93","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/j.1365-2036.2010.04366.x","volume":"32","author":"M Estep","year":"2010","unstructured":"Estep M, Armistead D, Hossain N et al (2010) Differential expression of miRNAs in the visceral adipose tissue of patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther 32:487\u2013497. https:\/\/doi.org\/10.1111\/j.1365-2036.2010.04366.x","journal-title":"Aliment Pharmacol Ther"},{"key":"11099_CR94","doi-asserted-by":"publisher","first-page":"336","DOI":"10.4093\/dmj.2019.0042","volume":"43","author":"W Wang","year":"2019","unstructured":"Wang W, Xu AL, Li ZC et al (2019) Combination of probiotics and salvia miltiorrhiza polysaccharide alleviates hepatic steatosis via gut microbiota modulation and insulin resistance improvement in high fat-induced NAFLD mice. Diabetes Metab J 43:336\u2013348. https:\/\/doi.org\/10.4093\/dmj.2019.0042","journal-title":"Diabetes Metab J"},{"key":"11099_CR95","doi-asserted-by":"publisher","unstructured":"Chen D, Liang Y, Liang J, Chen X et al (2023) Beneficial effects of Lactobacillus rhamnosus hsryfm 1301 fermented milk on rats with nonalcoholic fatty liver disease. J Dairy Sci 106:1533\u20131548. https:\/\/doi.org\/10.3168\/jds.2022-22383","DOI":"10.3168\/jds.2022-22383"},{"key":"11099_CR96","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s00394-021-02668-z","volume":"61","author":"V Vu","year":"2022","unstructured":"Vu V, Muthuramalingam K, Singh V et al (2022) Effects of \u03b2-glucan, probiotics, and synbiotics on obesity-associated colitis and hepatic manifestations in C57BL\/6J mice. Eur J Nutr 61:793\u2013807. https:\/\/doi.org\/10.1007\/s00394-021-02668-z","journal-title":"Eur J Nutr"},{"key":"11099_CR97","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1590\/0102-6720201700030011","volume":"30","author":"E Tagliari","year":"2017","unstructured":"Tagliari E, Campos AC, Thais Andrade Costa-Casagrande PRS (2017) The Impact of the Use of Symbiotics in the Progression of Nonalcoholic Fatty Liver Disease in a Rat Model. ABCD Arq Bras Cir Dig (S\u00e3o Paulo) 30:211\u2013215. https:\/\/doi.org\/10.1590\/0102-6720201700030011","journal-title":"ABCD Arq Bras Cir Dig (S\u00e3o Paulo)"},{"key":"11099_CR98","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3390\/nu9030198","volume":"9","author":"T Ren","year":"2017","unstructured":"Ren T, Zhu J, Zhu L, Cheng M (2017) The combination of blueberry juice and probiotics ameliorate non-alcoholic steatohepatitis (NASH) by affecting SREBP-1c\/PNPLA-3 pathway via PPAR-\u03b1. Nutrients 9:198. https:\/\/doi.org\/10.3390\/nu9030198","journal-title":"Nutrients"},{"key":"11099_CR99","first-page":"203","volume":"48","author":"J-J Zhu","year":"2017","unstructured":"Zhu J-J, Cheng M-L, Zhou M-Y, Zhao X-K (2017) The Effect of p-JAK1\/p-STAT3 Signaling Way in Intervening NAFLD by Blueberry Probiotic Serum. J Sichuan Univ (Medical Sci 48:203\u2013209","journal-title":"J Sichuan Univ (Medical Sci"},{"key":"11099_CR100","doi-asserted-by":"publisher","unstructured":"Wang J, Hao Y, Jin X et al (2022) Health effects of probiotics on nonalcoholic fatty liver in the life cycle based on data analysis. Comput Math Methods Med 2022(2123162). https:\/\/doi.org\/10.1155\/2022\/2123162","DOI":"10.1155\/2022\/2123162"},{"key":"11099_CR101","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1053\/jhep.2003.50048","volume":"37","author":"Z Li","year":"2003","unstructured":"Li Z, Yang S, Lin H et al (2003) Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology 37:343\u2013350. https:\/\/doi.org\/10.1053\/jhep.2003.50048","journal-title":"Hepatology"}],"container-title":["Probiotics and Antimicrobial Proteins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-026-11099-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12602-026-11099-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-026-11099-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T01:35:50Z","timestamp":1781228150000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12602-026-11099-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":101,"alternative-id":["11099"],"URL":"https:\/\/doi.org\/10.1007\/s12602-026-11099-3","relation":{},"ISSN":["1867-1306","1867-1314"],"issn-type":[{"value":"1867-1306","type":"print"},{"value":"1867-1314","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]},"assertion":[{"value":"10 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}